These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 680704)

  • 1. GLO I and Bf phenotype distribution in a West German population sample.
    Mauff G; Wachauf P; Schaal KP; Pulverer G
    Hum Hered; 1978; 28(6):431-4. PubMed ID: 680704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell glyoxalase I polymorphism in Alsace, France: linkage of GLO with Bf.
    North ML; Amann I; Tongio MM; Hauptmann G; Klein J; Mayer S
    Hum Hered; 1981; 31(1):39-41. PubMed ID: 6910464
    [No Abstract]   [Full Text] [Related]  

  • 3. No evidence for linkage disequilibrium between Bf and GLO in African negroids.
    Bender K; Mauff G; Hitzeroth HW
    Hum Genet; 1977 Sep; 38(2):227-30. PubMed ID: 908570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes.
    Kirk RL; Theophilus J; Whitehouse S; Court J; Zimmet P
    Diabetes; 1979 Oct; 28(10):949-51. PubMed ID: 478186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 1. Recombination frequencies.
    Kömpf J; Bissbort S; Göhler F; Schunter F; Wernet P
    Hum Genet; 1978 Nov; 44(3):313-9. PubMed ID: 730169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.
    Hamilton P; Middleton D
    Ulster Med J; 1988 Apr; 57(1):41-4. PubMed ID: 3166548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F; Wernet P; Kömpf J; Bissbort S; Göhler F
    Hum Genet; 1978 Nov; 44(3):321-31. PubMed ID: 730170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the population genetics of the red cell glyoxalase I (GLO).
    Stöhlmacher P; Haferland W
    Hum Genet; 1977 Dec; 39(3):303-4. PubMed ID: 598837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 10. Properdin factor Bf polymorphism and glyoxase I allotypes in Graves' disease.
    Wenzel KW; Wenzel BE; Weise W
    Tissue Antigens; 1981 Feb; 17(2):247-8. PubMed ID: 6908967
    [No Abstract]   [Full Text] [Related]  

  • 11. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLO polymorphism in Polish population.
    Schlesinger D; Hałasa J; Mańczak M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):173-6. PubMed ID: 749767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors Bf and glyoxalase in Basedow's disease].
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Guéguen M; Dinh KT; Le Gall JY; Genétet B
    Rev Med Interne; 1982 Jun; 3(2):129-32. PubMed ID: 6924395
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations on the polymorphism of glyoxalase I (EC 4.4.1.5) in the population of Hessen, Germany.
    Kühnl P; Schwabenland R; Spielmann W
    Hum Genet; 1977 Aug; 38(1):99-106. PubMed ID: 409660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Population-genetic examination of the glyoxalase I (GLO) red-cell isoenzyme system in the inhabitants of Szeged and its environment (South-Hungary) (author's transl)].
    Kósa F; Fekete-Csete K; Földes V
    Z Rechtsmed; 1982; 88(1-2):113-9. PubMed ID: 7080674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL; Ranford PR; Serjeantson SW; Thompson AR; Munirathnam Chetty SM; John L; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLO polymorphism in Iceland.
    Karlsson S; Arnason A; Jensson O
    Hum Hered; 1980; 30(6):383-5. PubMed ID: 7216230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of GPT and GLO-I in Galicia (northwest Spain): a comparative study.
    Caeiro JL; Carracedo A; Boán F
    Anthropol Anz; 1987 Mar; 45(1):63-70. PubMed ID: 3579235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glyoxalase I polymorphisms: distribution of phenotypes and gene frequencies in Portugal (author's transl)].
    Weissmann J; Pribilla O
    Z Rechtsmed; 1981; 86(3):205-11. PubMed ID: 7234136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.